Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07318207 · ClinicalTrials.gov registry record · NA

Time-restricted Eating for Patients With Type 2 Diabetes

A NA study of Type 2 Diabetes, sponsored by Justin (Matt) Thomas.

Recruiting
Registry status
NA
Development phase
102
Enrollment target
1
Study location

NCT07318207: Recruiting NA study of Type 2 Diabetes, sponsored by Justin (Matt) Thomas.

NCT07318207 is a NA study of Type 2 Diabetes that is actively recruiting participants, run by Justin (Matt) Thomas. The registered enrollment target is 102 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07318207, a NA study of Type 2 Diabetes, is actively recruiting participants, sponsored by Justin (Matt) Thomas.

RECRUITING
Registry status
NA
Development phase
102 participants
Enrollment target
1
Study location

Study Summary

This is a single-arm pragmatic clinical trial of time-restricted eating in patients with type 2 diabetes. Patients will be recruited from the University of Kentucky Barnstable Brown Diabetes Center. Subjects will participate in a 10-hour time-restricted eating intervention for 1-year.

Conditions Studied

Interventions

  • BEHAVIORAL Time-restricted eating

Study Locations (1)

Kentucky

  • University of Kentucky Barnstable Brown Diabetes Center - Lexington

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2026-04
Est. Completion 2027-06
Phase NA

Sponsor

Justin (Matt) Thomas

1 total trials

What the Registry Record Tells You About NCT07318207

The ClinicalTrials.gov registry entry for NCT07318207 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (91% lower). The listed sponsor is Justin (Matt) Thomas, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Time-restricted eating is the first listed.

NCT07318207 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT07318207 about?

NCT07318207 is a clinical study titled "Time-restricted Eating for Patients With Type 2 Diabetes". This is a single-arm pragmatic clinical trial of time-restricted eating in patients with type 2 diabetes. Patients will be recruited from the University of Kentucky Barnstable Brown Diabetes Center. Subjects will participate in a 10-hour time-restricted eating intervention for 1-year.

What is the current status of trial NCT07318207?

This trial is currently recruiting. It is a NA study. The enrollment target is 102 participants. The study started on 2026-04. Estimated completion is 2027-06.

What conditions does trial NCT07318207 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT07318207?

The interventions under investigation include: Time-restricted eating (BEHAVIORAL).

Who is sponsoring clinical trial NCT07318207?

This trial is sponsored by Justin (Matt) Thomas, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07318207 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.